Skip to main content
. 2023 Aug 22;24(17):13034. doi: 10.3390/ijms241713034

Figure 1.

Figure 1

Prognostic value of miR-616 in subtypes of breast cancer. TNMplot (https://tnmplot.com/analysis/, accessed on 10 August 2022) was used to determine the expression of CHOP and miR-616 in human breast cancer. (A) Box plot for expression of CHOP in tumor (n = 1097) and normal (n = 403) tissues for human breast cancers is shown. (B) Box plot for expression of miR-616 in paired tumor (n = 112) and tumor-adjacent normal (n = 112) for human breast cancers is shown. (C) KM Plotter (https://kmplot.com/, accessed on 2 October 2022) was used to determine the association of miR-616 with overall survival (OS) in subtypes of breast cancer.